Diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas

Diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas

Authors

  • Pablo Cortegoso Valdivia Gastroenterology Unit, Molinette Hospital, Torino University, Torino
  • Claudia Chialà Gastroenterology Unit, Molinette Hospital, Torino University, Torino
  • Ludovica Venezia Gastroenterology Unit, Molinette Hospital, Torino University, Torino
  • Federica Gaiani Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy
  • Gioacchino Leandro National Institute of Gastroenterology “S. De Bellis” Research Hospital, Castellana Grotte, Italy
  • Francesco Di Mario Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy
  • Gian Luigi de' Angelis Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy

Keywords:

intraductal papillary mucinous neoplasms

Abstract

Background and aim of the work: Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are cystic lesions with malignant potential. Given their increasing incidence in the latest years, a precise characterization and management of these lesions have become more and more crucial: even though the majority of IPMN has a benign and indolent course, it is fundamental to early recognize and stratify patients in order to accurately plan a tailored follow-up and to individuate those that would benefit of surgical treatment. The aim of this paper is to highlight the most recent evidence on IPMN available in the current literature. Methods: We performed a review of the recent literature and of the recent guidelines about pancreatic cystic lesions, especially IPMN. Results: The incidence of IPMN is now on the rise: an increasing number of patients, possibly because of the increasing diagnostic yield of imaging techniques, is being diagnosed with pancreatic cystic lesions, a great part of which are IPMN. The possibility of malignant transformation requires a careful approach to these patients, in the need of tailoring the follow-up and the therapy. Conclusion: A detailed diagnosis, the determination of risk factors for malignant transformation and a multisciplinary approach are of foremost importance for an effective management of IPMN.

Downloads

Published

17-12-2018

How to Cite

1.
Diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Acta Biomed [Internet]. 2018 Dec. 17 [cited 2024 Mar. 29];89(9-S):147-52. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/7958